The role of miR-148a in gastric cancer

被引:62
|
作者
Xia, Jiazeng [1 ,2 ]
Guo, Xiaoqiang [1 ,2 ]
Yan, Jiang [1 ,2 ]
Deng, Kaiyuan [1 ,2 ]
机构
[1] Nanjing Med Univ, Dept Gen Surg, Affiliated Wuxi Hosp 2, Wuxi 214002, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Translat Med Ctr, Affiliated Wuxi Hosp 2, Wuxi 214002, Jiangsu, Peoples R China
关键词
miR-148a; Gastric cancer; MicroRNA; Methylation; CIRCULATING MICRORNAS; CELL-PROLIFERATION; EXPRESSION; METASTASIS; BIOMARKERS; SIGNATURE; DATABASE; DNMT1; MEG3;
D O I
10.1007/s00432-014-1649-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer is one of the most common malignant diseases worldwide, although much progress has been achieved in recent years, the early diagnosis and treatment for gastric cancer are not yet satisfactory and, thus the prognosis is still poor. MicroRNAs (miRNAs) can regulate a variety of physiological and developmental processes, it has been revealed that many miRNAs contribute the initiation and progression of various cancers. MiR-148a is one of the most important miRNAs in gastric cancer, and the aim of this paper is to provide an overview of various roles of miR-148a in gastric cancer. We searched studies in electronic databases. MiR-148a was down-regulated in gastric cancer tissues and cell lines, which was resulted from the hypermethylation in its promoter region. Furthermore, miR-148a could regulate several different target genes and pathways involving tumor proliferation, invasion and metastasis. MiR-148a may serve as a novel biomarker for the diagnosis and as a new therapeutic target in gastric cancer.
引用
收藏
页码:1451 / 1456
页数:6
相关论文
共 50 条
  • [1] The role of miR-148a in gastric cancer
    Jiazeng Xia
    Xiaoqiang Guo
    Jiang Yan
    Kaiyuan Deng
    [J]. Journal of Cancer Research and Clinical Oncology, 2014, 140 : 1451 - 1456
  • [2] The Role of Mir-148a in Cancer
    Li, Yue
    Deng, Xiyun
    Zeng, Xiaomin
    Peng, Xiaoning
    [J]. JOURNAL OF CANCER, 2016, 7 (10): : 1233 - 1241
  • [3] The role of miR-148a in pancreatic cancer cells
    Wang, Yalei
    Feng, Hui
    Yao, Weiyan
    Chen, Xi
    Zhang, Chenyu
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 231 - 232
  • [4] MIR-148A HAS A THERAPEUTIC POTENTIAL TO SUPPRESS GASTRIC CANCER METASTASIS
    Zheng, B. Q.
    Shi, Y. Q.
    He, X. H.
    Liang, L. H.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 31 - 31
  • [5] MiR-148a induces apoptosis by upregulating BIM expression in gastric cancer cells
    Zhang, Maoshen
    Wang, Chenghong
    Mu, Lihua
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2791 - 2799
  • [6] MiR-148a/b function as tumor suppressors in gastric cancer by targeting PrPc
    Shi, Xiaolei
    Tie, Jun
    Hu, Sijun
    Nie, Yongzhan
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 867 - 867
  • [7] Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer
    Hibino, Yumi
    Sakamoto, Naoya
    Naito, Yutaka
    Goto, Keisuke
    Oo, Htoo Zarni
    Sentani, Kazuhiro
    Hinoi, Takao
    Ohdan, Hideki
    Oue, Naohide
    Yasui, Wataru
    [J]. PATHOBIOLOGY, 2015, 82 (05) : 233 - 241
  • [8] miR-148a Promoted Cell Proliferation by Targeting p27 in Gastric Cancer Cells
    Guo, Shui-Long
    Peng, Zheng
    Yang, Xue
    Fan, Kai-Ji
    Ye, Hui
    Li, Zhen-Hua
    Wang, Yan
    Xu, Xiao-Li
    Li, Jun
    Wang, You-Liang
    Teng, Yan
    Yang, Xiao
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2011, 7 (05): : 567 - 574
  • [9] miR-148a suppresses cell invasion and migration in gastric cancer by targeting DNA methyltransferase 1
    Shi, Huaijie
    Chen, Xiaojing
    Jiang, Hao
    Wang, Xujie
    Yu, Hao
    Sun, Pijiang
    Sui, Xin
    [J]. ONCOLOGY LETTERS, 2018, 15 (04) : 4944 - 4950
  • [10] MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1
    Yan, Jiang
    Guo, Xiaoqiang
    Xia, Jiazeng
    Shan, Tin
    Gu, Chen
    Liang, Zheng
    Zhao, Wei
    Jin, Shimao
    [J]. MEDICAL ONCOLOGY, 2014, 31 (03)